New era of left main coronary artery treatment strategy
Seung-Jung Park1, Duk-Woo Park
1Division of Cardiology, Asan Medical Center, University of Ulsan College of Medicine, 388-1 Poongnap-dong, Songpa-gu, Seoul, 138-736, Korea, sjpark@amc.seoul.kr.
Insights
Percutaneous coronary intervention (PCI) with drug-eluting stents (DES) offers similar safety outcomes to coronary-artery bypass grafting (CABG) for unprotected left main coronary artery (LMCA) disease. PCI may become a preferred revascularization strategy, potentially altering clinical guidelines.
Area of Science:
- Interventional Cardiology
- Cardiovascular Surgery
- Medical Device Technology
Background:
- Coronary-artery bypass grafting (CABG) has historically been the gold standard for unprotected left main coronary artery (LMCA) disease.
- Advancements in percutaneous coronary intervention (PCI) techniques, devices, and pharmacologic therapies have introduced PCI with drug-eluting stent (DES) implantation as a viable alternative.
Purpose of the Study:
- To evaluate the safety and efficacy of PCI with DES implantation compared to CABG for unprotected LMCA disease.
- To assess the evolving role of PCI in the revascularization strategy for unprotected LMCA disease.
Main Methods:
- Review and synthesis of cumulative evidence from clinical trials and observational studies comparing PCI with DES versus CABG for unprotected LMCA disease.
- Analysis of safety outcomes (mortality, death, myocardial infarction, stroke) and efficacy outcomes (repeat revascularization).
Main Results:
- Safety outcomes, including mortality and the composite of death, myocardial infarction, and stroke, are comparable between PCI with DES and CABG for unprotected LMCA disease.
- The primary difference observed is a higher rate of repeat revascularization following PCI compared to CABG.
Conclusions:
- Current evidence supports PCI with DES as a safe alternative revascularization strategy for select patients with unprotected LMCA disease.
- Ongoing clinical trials and accumulating data are likely to influence future clinical practice guidelines and treatment recommendations for unprotected LMCA disease.
Abstract:
For several decades of medical history, coronary-artery bypass grafting (CABG) has been regarded as the best treatment option for patients with unprotected left main coronary artery (LMCA) disease, considering lesion priority and its clinical consequences. Over the time, with remarkable advancements in techniques of percutaneous coronary intervention (PCI), supporting devices, and adjunctive pharmacologic therapy, PCI with DES implantation has appeared to be new and alternative option for optimal revascularization therapy for these patients. The available cumulative evidence suggests that the safety outcomes such as mortality or composite of death, myocardial infarction and stroke are similar among PCI and CABG for patients with LMCA disease, the only difference was the rate of repeat revascularization. Current evidence and ongoing large clinical trials may encourage interventional cardiologists to choose PCI with stenting as an alternative revascularization strategy for unprotected LMCA disease in future. Finally, this evidence will change the current clinical practice and the guideline of optimal revascularization strategy for unprotected LMCA disease.
Related Concept Videos
01:27Coronary Artery Disease V: Interprofessional Care
01:26Mitral Stenosis III: Medical Management
01:24Cardiac Catheterization III: Left Heart Catheterization
01:28Acute Coronary Syndrome IV: Interprofessional Care
01:26Angina IV: Management
01:26Coronary Artery Disease IV: Preventive Measures